Skip to content- XW02 Muscle
- XW020 Open
- XW020D Engineered Allogeneic Thymus Tissue
- XW020D8 Introduction of Engineered Allogeneic Thymus Tissue into Muscle, Open Approach, New Technology Group 8
- XW023 Percutaneous
- XW023S COVID-19 Vaccine Dose 1
- XW023S6 Introduction of COVID-19 Vaccine Dose 1 into Muscle, Percutaneous Approach, New Technology Group 6
- XW023T COVID-19 Vaccine Dose 2
- XW023T6 Introduction of COVID-19 Vaccine Dose 2 into Muscle, Percutaneous Approach, New Technology Group 6
- XW023U COVID-19 Vaccine
- XW023U6 Introduction of COVID-19 Vaccine into Muscle, Percutaneous Approach, New Technology Group 6
- XW023V COVID-19 Vaccine Dose 3
- XW023V7 Introduction of COVID-19 Vaccine Dose 3 into Muscle, Percutaneous Approach, New Technology Group 7
- XW023W COVID-19 Vaccine Booster
- XW023W7 Introduction of COVID-19 Vaccine Booster into Muscle, Percutaneous Approach, New Technology Group 7
- XW023X Tixagevimab and Cilgavimab Monoclonal Antibody
- XW023X7 Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7
- XW023Y Other New Technology Monoclonal Antibody
- XW023Y7 Introduction of Other New Technology Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7
error: Content is protected !!